ITI Pharma and Healthcare Fund Direct Growth
3Y Annualised
21.20%
-0.65% 1D
Fund Performance
Fund Multiplier
Fund Info
Peer Comparison
Fund Managers
AMC Details
Performance
1M Returns
3.40%
-0.65% 1D
Benchmark
N/A
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
3 years 7 months
5 years 5 months
9 years 7 months
Fund info
Fund size
₹226.89 Cr
Min. SIP amount
₹500
Min. Lumpsum amount
₹5000
Exit load
0.01%
1% - If redeemed or switched out on or before completion of 12 months from the date of allotment of units. Nil - If redeemed or switched out after completion of 12 months from the date of allotment of units.
Risk Profile
Very High Risk
This Fund's Performance Compared With Peers
Over the Period of oneMonth
1st
ICICI Prudential Nifty Healthcare ETF
2nd
DSP Nifty Healthcare ETF
3rd
PGIM India Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl
4th
PGIM India Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
5th
PGIM India Healthcare Fund Direct Growth
38th
ITI Pharma and Healthcare Fund Direct Growth
Fund Managers
About ITI Pharma and Healthcare Fund Direct Growth
ITI Pharma and Healthcare Fund Direct Growth is a Equity mutual fund scheme from ITI Asset Management Limited. This fund has been in existence for 3 years, having been launched on 2021-11-11. ITI Pharma and Healthcare Fund Direct Growth has ₹226.89 Cr worth of assets under management (AUM) as of Sun Nov 02 2025. The latest Net Asset Value (NAV) of ITI Pharma and Healthcare Fund Direct Growth as of Fri Oct 31 2025 is ₹17.6717. The fund has an expense ratio of 0.47%, which is medium comparable to most other Equity funds.
ITI Pharma and Healthcare Fund Direct Growth returns for the last 1 year are -2.24%. Since launch, it has delivered 15.41% average annual returns.
The ITI Pharma and Healthcare Fund Direct Growth has the majority of its money invested in Healthcare sectors.
Top 5 Holdings of ITI Pharma and Healthcare Fund Direct Growth.
- Sun Pharmaceuticals Industries Ltd: 10.62%
- Divi's Laboratories Ltd: 7.79%
- Apollo Hospitals Enterprise Ltd: 5.81%
- Max Healthcare Institute Ltd Ordinary Shares: 5.70%
- Cohance Lifesciences Ltd: 5.06%
AMC Information
| Name | ITI Asset Management Limited |
|---|---|
| Founding Date | 2021-11-11 |
| mfassist@itiorg.com | |
| Phone | 022-66214999 |
| Website | www.itimf.com |
| Address | Naman Midtown “A” Wing, 21st Floor, Senapati Bapat Marg, Elphinstone Road |
Tax Implications of ITI Pharma and Healthcare Fund Direct Growth
| Short Term Gains | 20% + applicable Surcharge + 4% Cess |
|---|---|
| Long Term Gains | 12.5% without indexation + applicable Surcharge + 4% Cess |
Similar Funds from ITI Asset Management Limited
Alternative StrategiesArbitrage Fund
3Y CAGR
6.55%
expense ratio
0.93%
fund size
₹50.72 Cr
Alternative StrategiesArbitrage Fund
3Y CAGR
7.34%
expense ratio
0.21%
fund size
₹50.72 Cr
Capital PreservationLiquid
3Y CAGR
6.68%
expense ratio
0.25%
fund size
₹63.29 Cr
Capital PreservationLiquid
3Y CAGR
6.85%
expense ratio
0.09%
fund size
₹63.29 Cr
EquityMulti-Cap
3Y CAGR
20.97%
expense ratio
0.66%
fund size
₹1261.32 Cr
Calculate Your Returns
Estimated Returns in 3 Years (Based on past 3Y returns)
₹0
Total Amount
₹0


